Scientists discover prototype test to help in fighting deadly melanoma ANI | Updated: Feb 21, 2021 23:23 IST
Washington [US], February 21 (ANI): A team of scientists from Australia published a study in the journal Clinical Cancer Research that shows their new discovery of a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.
Australian researchers from QIMR Berghofer Medical Research Institute conducted the study. Details about the test and the research have been published on Monday (local time) in Clinical Cancer Research, a journal of the American Association for Cancer Research.
The prototype test detects levels of the protein LC3B on cancer cells. High levels of LC3B are associated with better patient responses to a form of treatment known as checkpoint inhibitor immunotherapy.
Prototype test to help fight deadly melanoma
newzealandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newzealandstar.com Daily Mail and Mail on Sunday newspapers.
It s beautiful : how birthing on country can reduce stillbirth for Aboriginal women
smh.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smh.com.au Daily Mail and Mail on Sunday newspapers.
âToo many think silence is consentâ: Victim says rape âendemicâ in eastern suburbs
Weâre sorry, this service is currently unavailable. Please try again later.
Dismiss
Save
Normal text size
Advertisement
A young woman from the eastern suburbs who secured a conviction against a former friend who raped her at a party says the court process is traumatising and Australia still has a culture of blaming the victim.
In a week where the national focus was on former political staffer Brittany Higgins, who was allegedly raped by a colleague at Parliament House two years ago, Elena Brown (not her real name) was reliving her own ordeal after it was reported in the media last weekend.